ACS Appl Mater Interfaces. 2019 May 1;11(17):15436-15446. doi: 10.1021/acsami.9b04603. Epub 2019 Apr 16.
Phosphate-based glasses (PBGs) are bioactive and fully degradable materials with tailorable degradation rates. PBGs can be produced as porous microspheres through a single-step process, using changes in their formulation and geometry to produce varying pore sizes and interconnectivity for use in a range of applications, including biomedical use. Calcium phosphate PBGs have recently been proposed as orthobiologics, based on their in vitro cytocompatibility and ion release profile. In this study, porous microspheres made of two PBG formulations either containing TiO (P40Ti) or without (P40) were implanted in vivo in a large animal model of bone defect. The biocompatibility and osteogenic potential of these porous materials were assessed 13 weeks postimplantation in sheep and compared to empty defects and autologous bone grafts used as negative and positive controls. Histological analysis showed marked differences between the two formulations, as lower trabeculae-like interconnection and higher fatty bone marrow content were observed in the faster degrading P40-implanted defects, while the slower degrading P40Ti material promoted dense interconnected tissue. Autologous bone marrow concentrate (BMC) was also incorporated within the P40 and P40Ti microspheres in some defects; however, no significant differences were observed in comparison to microspheres implanted alone. Both formulations induced the formation of a collagen-enriched matrix, from 20 to 40% for P40 and P40Ti2.5 groups, suggesting commitment toward the bone lineage. With the faster degrading P40 formulation, mineralization of the tissue matrix was observed both with and without BMC. Some lymphocyte-like cells and foreign body multinucleated giant cells were observed with P40Ti2.5, suggesting that this more durable formulation might be linked to an inflammatory response. In conclusion, these first in vivo results indicate that PBG microspheres could be useful candidates for bone repair and regenerative medicine strategies and highlight the role of material degradation in the process of tissue formation and maturation.
基于其体外细胞相容性和离子释放特性,磷酸钙玻璃(PBG)被认为是一种具有生物活性且可完全降解的材料,并且其降解速率可调控。通过一步法工艺可制备出多孔微球,通过改变其配方和几何形状,可产生不同的孔径和连通性,从而应用于多种领域,包括生物医学领域。最近,有人提出将磷酸钙玻璃作为组织工程生物材料,基于其体外细胞相容性和离子释放特性。在这项研究中,将两种 PBG 配方(一种含有 TiO2(P40Ti),另一种不含 TiO2(P40))制成的多孔微球植入大动物骨缺损模型体内。在植入 13 周后,评估这些多孔材料的生物相容性和成骨潜能,并与空白缺陷和自体骨移植物(阴性和阳性对照)进行比较。组织学分析显示两种配方之间存在明显差异,在降解速度较快的 P40 植入缺陷中,观察到较低的小梁样连接和较高的脂肪骨髓含量,而降解速度较慢的 P40Ti 材料促进了致密的相互连接组织。在一些 P40 和 P40Ti 微球中也掺入了自体骨髓浓缩物(BMC);然而,与单独植入微球相比,没有观察到显著差异。两种配方都诱导了富含胶原蛋白的基质形成,P40 和 P40Ti2.5 组分别为 20%到 40%,这表明它们向成骨细胞谱系分化。在具有较快降解速度的 P40 配方中,观察到有和没有 BMC 时组织基质都有矿化。在 P40Ti2.5 中观察到一些淋巴细胞样细胞和异物多核巨细胞,这表明这种更持久的配方可能与炎症反应有关。总之,这些初步的体内结果表明,PBG 微球可能是骨修复和再生医学策略的有用候选物,并强调了材料降解在组织形成和成熟过程中的作用。